Search
for
Sort by
Research 61–90 of 284
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
- Targeting the Wnt pathways for therapies
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Redefining hormone resistance in prostate cancer
- Characterisation of cell cycle arrest and terminal differentiation in a maximally proliferative human epithelial tissue: Lessons from the human hair follicle matrix
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Molecular pathology of skin adnexal tumours
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Progress in Relevant Growth Factors Promoting the Growth of Hair Follicle
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Purified Vitexin Compound 1 Inhibits UVA-Induced Cellular Senescence in Human Dermal Fibroblasts by Binding Mitogen-Activated Protein Kinase 1
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- Management of Toxicities of Targeted Therapies
- Chemotherapy-Induced Alopecia
- Ether: Fiction or Reality? A Review
- Cutaneous drug reactions
- МИКРОБИОЦЕНОЗ ЛУНОК УДАЛЕННЫХ ЗУБОВ У ПАЦИЕНТОВ С АЛЬВЕОЛИТОМ
- Cutaneous gain-of-function mutation of LRIG3 leads to alopecia by upregulation of ERBB, PI3K/AKT, NOTCH1 signaling pathways
- Alopecia induced by CDK 4/6 Inhibitors and its Impact on the Quality of Life of Patients with advanced Breast cancer
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Fibroblast heterogeneity and functions: insights from single-cell sequencing in wound healing, breast cancer, ovarian cancer and melanoma
- Kalya Research: Complementary and Alternative Medicine (CAM) Virtual Research Assistant from Biomedical Literature
- DETERMINATION OF THE DEGREE OF TISSUE HEATING UNDER THE EXPOSURE TO LASER RADIATION WITH A WAVELENGTH OF 445±40 NM
- THE GLOBAL CHALLENGE OF CHEMOTHERAPY TOXICITY: RETHINKING SUPPORTIVE CARE IN MODERN ONCOLOGY
- Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors
- LncRNA PlncRNA‑1 regulates proliferation and differentiation of hair follicle stem cells through TGF‑β1‑mediated Wnt/β‑catenin signal pathway